208 related articles for article (PubMed ID: 33088813)
1. Prescribing Habits for Androgenic Alopecia among Dermatologists in Spain in 2019-2020: A Cross-Sectional Study.
Pindado-Ortega C; Saceda-Corralo D; Fernández-Nieto D; Jiménez-Cauhé J; Ortega-Quijano D; Moreno-Arrones ÓM; Vañó-Galván S
Skin Appendage Disord; 2020 Sep; 6(5):283-286. PubMed ID: 33088813
[TBL] [Abstract][Full Text] [Related]
2. Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study.
Pindado-Ortega C; Saceda-Corralo D; Buendía-Castaño D; Fernández-González P; Moreno-Arrones ÓM; Fonda-Pascual P; Alegre-Sánchez A; Rodrigues-Barata AR; Vañó-Galván S
Actas Dermosifiliogr (Engl Ed); 2018; 109(6):536-542. PubMed ID: 29656764
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial.
Sadeghzadeh Bazargan A; Tavana Z; Dehghani A; Jafarzadeh A; Tabavar A; Alavi Rad E; Goodarzi A
J Cosmet Dermatol; 2024 Feb; 23(2):543-551. PubMed ID: 37650533
[TBL] [Abstract][Full Text] [Related]
4. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
Gupta AK; Talukder M; Williams G
J Dermatolog Treat; 2022 Nov; 33(7):2946-2962. PubMed ID: 35920739
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia.
Gupta AK; Talukder M; Shemer A
Expert Opin Pharmacother; 2024 Feb; 25(2):139-147. PubMed ID: 38315101
[TBL] [Abstract][Full Text] [Related]
6. Hair loss in women.
Camacho-Martínez FM
Semin Cutan Med Surg; 2009 Mar; 28(1):19-32. PubMed ID: 19341939
[TBL] [Abstract][Full Text] [Related]
7. Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics.
Gao JL; Streed CG; Thompson J; Dommasch ED; Peebles JK
J Am Acad Dermatol; 2023 Oct; 89(4):774-783. PubMed ID: 34756934
[TBL] [Abstract][Full Text] [Related]
8. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
9. Topical minoxidil fortified with finasteride: An account of maintenance of hair density after replacing oral finasteride.
Chandrashekar BS; Nandhini T; Vasanth V; Sriram R; Navale S
Indian Dermatol Online J; 2015; 6(1):17-20. PubMed ID: 25657911
[TBL] [Abstract][Full Text] [Related]
10. Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.
Gupta AK; Venkataraman M; Talukder M; Bamimore MA
JAMA Dermatol; 2022 Mar; 158(3):266-274. PubMed ID: 35107565
[TBL] [Abstract][Full Text] [Related]
11. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
[TBL] [Abstract][Full Text] [Related]
12. Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature.
Mercuri SR; Paolino G; Di Nicola MR; Vollono L
Medicina (Kaunas); 2021 Mar; 57(4):. PubMed ID: 33806169
[No Abstract] [Full Text] [Related]
13. A Proposal of an Effective Platelet-rich Plasma Protocol for the Treatment of Androgenetic Alopecia.
Ferrando J; García-García SC; González-de-Cossío AC; Bou L; Navarra E
Int J Trichology; 2017; 9(4):165-170. PubMed ID: 29118521
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study.
Milani M; Colombo F;
Skin Res Technol; 2023 Jun; 29(6):e13381. PubMed ID: 37357646
[TBL] [Abstract][Full Text] [Related]
15. Psychological features of androgenetic alopecia.
Camacho FM; García-Hernández M
J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):476-80. PubMed ID: 12428841
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
Suchonwanit P; Iamsumang W; Rojhirunsakool S
Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
[TBL] [Abstract][Full Text] [Related]
18. Finasteride in the treatment of female pattern (androgenic) alopecia: a case report and review of the literature.
Boychenko O; Bernstein RM; Schweiger ES
Cutis; 2012 Aug; 90(2):73-6. PubMed ID: 22988650
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data.
Abeck F; Hansen I; Kött J; Schröder F; Garrahy E; Veneroso J; Rünger A; Torster L; Schneider SW; von Büren J
J Cosmet Dermatol; 2024 May; ():. PubMed ID: 38713003
[TBL] [Abstract][Full Text] [Related]
20. Frontal edema due to mesotherapy for androgenetic alopecia: A case series.
Melo DF; Saceda-Corralo D; Tosti A; Weffort F; Carla Jorge M; de Barros CC; de Melo Carvalho R; Starace M
Dermatol Ther; 2022 Feb; 35(2):e15247. PubMed ID: 34877759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
